Cargando…
Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix(®) or Gardasil(®) Vaccine
BACKGROUND: Human papillomavirus (HPV) vaccines confer protection against the oncogenic genotypes HPV16 and HPV18 through the generation of type-specific neutralizing antibodies raised against virus-like particles (VLP) representing these genotypes. The vaccines also confer a degree of cross-protect...
Autores principales: | Godi, Anna, Bissett, Sara L., Miller, Elizabeth, Beddows, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619723/ https://www.ncbi.nlm.nih.gov/pubmed/26495976 http://dx.doi.org/10.1371/journal.pone.0140926 |
Ejemplares similares
-
Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
por: Roy, Vicky, et al.
Publicado: (2023) -
Impact of HPV vaccination with Gardasil® in Switzerland
por: Jacot-Guillarmod, Martine, et al.
Publicado: (2017) -
Cervarix(™): a vaccine for the prevention of HPV 16, 18-associated cervical cancer
por: Monie, Archana, et al.
Publicado: (2008) -
A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix(®) and Gardasil(®) Human Papillomavirus Vaccines in 12-15 Year Old Girls
por: Draper, Eve, et al.
Publicado: (2013) -
Update on Safety and Efficacy of HPV Vaccines: Focus on Gardasil
por: Soliman, Monica, et al.
Publicado: (2021)